Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: Correlation with behaviour

European Journal of Neuroscience

Volumn 15, Issue 7, 2002, Pages 1178-1186

  Maccarrone, Mauro ^a   Valverde, Olga ^b   Barbaccia, Maria L ^a   Castañé, Anna ^b   Maldonado, Rafael ^b   Ledent, Catherine ^c   Parmentier, Marc ^c   Finazzi Agrò, Alessandro ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Anandamide hydrolase; Anandamide transporter; Anxiety related behaviour; CD1 mice; Endocannabinoids

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; FATTY ACID AMIDASE; HYDROLASE; PROTEIN;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BIOLOGICAL MODEL; BRAIN CORTEX; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DARKNESS; ENZYME ACTIVITY; ENZYME ANALYSIS; HIPPOCAMPUS; KNOCKOUT MOUSE; LIGHT; METABOLISM; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RECEPTOR GENE; RECOGNITION; WILD TYPE; WITHDRAWAL SYNDROME;

ADAPTATION, PHYSIOLOGICAL; AGING; AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CARRIER PROTEINS; CEREBRAL CORTEX; DOWN-REGULATION; ENDOCANNABINOIDS; HIPPOCAMPUS; MICE; MICE, KNOCKOUT; NEURONS; PAIN; PAIN THRESHOLD; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECOGNITION (PSYCHOLOGY); SUBSTANCE WITHDRAWAL SYNDROME; SYNAPTOSOMES;

EID: 18744396333     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2002.01957.x     Document Type: Article

References (53)

1. Barbaccia, M.L., Gandolfi, O., Chuang, D.-M. & Costa, E. (1983) Modulation of neuronal serotonin uptake by the imipramine recognition site: Evidence for an endogenous ligand. Proc. Natl Acad. Sci. USA, 80, 5134-5138.
2. 2 receptor responses by an anandamide transport inhibitor. J. Neurosci., 20, 3401-3407.
3. Bisogno, T., Maurelli, S., Melck, D., De Petrocellis, L. & Di Marzo, V. (1997) Biosynthesis, uptake and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem., 272, 3315-3323.
4. 1a serotonin receptor potentiation by the biologically active lipid oleamide. Proc. Natl Acad. Sci. USA, 95, 4102-4107.
5. 1 receptors. Neurosci., 95, 5-7.
6. Breivogel, C.S., Griffin, G., Di Marzo, V. & Martin, B.R. (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155-163.
7. Cadas, H., di Tomaso, E. & Piomelli, D. (1997) Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci., 17, 1226-1242.
8. Chaperon, F. & Thiebot, M.H. (1999) Behavioural effects of cannabinoid agents in animals. Crit. Rev. Neurobiol., 13, 243-281.
9. Cheer, J.F., Cadogan, A.K., Marsden, C.A., Fone, K.C. & Kendall, D.A. (1999) Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology, 38, 533-541.
10. Deutsch, D.G. & Chin, S.A. (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol., 46, 791-796.
11. Devane, W.A., Hannus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
12. 9-tetrahydrocannabinol-tolerant rats. J. Neurochem., 74, 1627-1635.
13. Di Marzo, V., Melck, D., Orlando, P., Bisogno, T., Zagoory, O., Bifulco, M., Vogel, Z. & De Petrocellis, L. (2001) Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem. J., 358, 249- 255.
14. 1 receptors by cannabinoids. Eur. J. Neurosci., 10, 2825-2830.
15. File, S.E., Kenny, P.J. & Cheeta, S. (2000) The role of dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav., 66, 65-72.
16. Galve-Roperh, I., Sànchez, C., Cortes, M.L., del Pulgar, T.G., Izquierdo, M. & Guzman, M. (2000) Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nature Med., 6, 313-316.
17. Goparaju, S.K., Ueda, N., Taniguchi, K. & Yamamoto, S. (1999) Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol., 57, 417-423.
18. Goparaju, S.K., Ueda, N., Yamaguchi, H. & Yamamoto, S. (1998) Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett., 422, 69-73.
19. Hajos, N., Katona, I., Naiem, S.S., Ledent, C., Mody, I. & Freund, T.F. (2000) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci., 12, 3239-3249.
20. Hampson, A.J. Bornheim, L.M., Scanziani, M., Yost, C.S., Gray, A.T., Hansen, B.M., Leonoudakis, D.J. & Bickler, P.E. (1998) Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J. Neurochem., 70, 671-676.
21. Hansen, H.S., Moesgaard, B., Hansen, H.H., Schousboe, A. & Petersen, G. (1999) Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity. Lipids, 34, S327-S330.
22. Hillard, C.J., Edgemond, W.S., Jarrahian, A. & Campbell, W.B. (1997) Accumulation of N-arachidonoylethanolamide (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem., 69, 631-638.
23. Hunskaar, S., Fasmer, O.B. & Hole, K. (1985) Formalin test in mice, a useful technique for evaluating mild analgesics. J. Neurosci. Meth, 14, 69-76.
24. Jarrahian, A., Manna, S., Edgemond, W.S., Campbell, W.B. & Hillard, C.J. (2000) Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter. J. Neurochem., 74, 2597-2606.
25. Katona, I., Sperlagh, B., Sik, A., Kafalvi, A., Vizi, E.S., Mackie, K. & Freund, T.F. (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci., 19, 4544-4558.
26. 1 receptor knockout mice. Science, 283, 401-404.
27. Lichtman, A.H., Dimen, K.R. & Martin, B.R. (1995) Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology, 119, 282-290.
28. 1 cannabinoid receptor knockout mice of different ages. J. Neurochem., 78, 339-348.
29. Maccarrone, M., Attinà, M., Cartoni, A., Bari, M. & Finazzi-Agrò, A. (2001a) GC/MS analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture. J. Neurochem., 76, 594-601.
30. Maccarrone, M., Bari, M., Lorenzon, T., Bisogno, T., Di Marzo, V. & Finazzi-Agrò, A. (2000a) Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem., 275, 13484-13492.
31. Maccarrone, M., Lorenzon, T., Bari, M., Melino, G. & Finazzi-Agrò, A. (2000c) Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem., 275, 31938-31945.
32. Maccarrone, M., Valensise, H., Bari, M., Lazzarin, N., Romanini, C. & Finazzi-Agrò, A. (2000b) Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet, 355, 1326-1329.
33. Maccarrone, M., van der Stelt, M., Rossi, A., Veldink, G.A., Vliegenthart, J.F.G. & Finazzi-Agrò, A. (1998) Anandamide hydrolysis by human cells in culture and brain. J. Biol. Chem., 273, 32332-32339.
34. Maldonado, R., Negus, S. & Koob, G.F. (1992) Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology, 31, 1231-1241.
35. Martin, M., Ledent, C., Parmentier, M., Maldonado, R. & Valverde, O. (2002) Involvement of CB1 cannabinoid receptors in emotional behavior. Psychopharmacology, in press.
36. Meziane, H., Dodart, J.C., Mathis, C., Little, C., Clemens, J., Pul, S.M. & Ungerer, A. (1998) Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl Acad. Sci. USA, 95, 12683-12688.
37. Nakazi, M., Bauer, U., Nickel, T., Kathmann, M. & Schlicker, E. (2000) Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid (CB)1 receptors. Naunyn Schmiedebergs Arch. Pharmacol., 361, 19-24.
38. Noble, F., Smadja, C., Valverde, O., Maldonado, R., Coric, P., Turcaud, S., Fournié-Zaluski, M.-C. & Roques, B.P. (1997) Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120. Pain, 73, 383-391.
39. 2 receptors. Pharmacol. Ther., 74, 129-180.
40. Piomelli, D., Giuffrida, A., Calignano, A. & Rodriguez de Fonseca, F. (2000) The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol. Sci., 21, 218-224.
41. Pop, E. (1999) Cannabinoids, endogenous ligands and synthetic analogs. Curr. Opin. Chem. Biol., 3, 418-425.
42. 1 receptor knock-out mice. Eur. J. Pharmacol., 379, R1-R2.
43. Rodríguez de Fonseca, F., Rubio, P., Menzaghi, F., Merlo-Pich, E., Rivier, J., Koob, G.F. & Navarro, M. (1996) Corticotrophin-releasing factor (CRF) antagonist {D-Phe12, Nle21,38,C alpha MeLeu37} CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J. Pharmacol. Exp. Ther., 276, 56-64.
44. Salzet, M., Breton, C., Bisogno, T. & Di Marzo, V. (2000) Comparative biology of the endocannabinoid system Possible role in the immune response. Eur. J. Biochem., 267, 4917-4927.
45. Schmid, P.C., Krebsbach, R.J., Perry, S.R., Dettmer, T.M., Maasson, J.L. & Schmid, H.H. (1995) Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett., 375, 117-120.
46. Self, D.W. (1999) Anandamide: A candidate neurotransmitter heads for the big leagues. Nature Neurosci., 2, 303-304.
47. Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B.P., Maldonado, R. & Kieffer, B.L. (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J., 17, 886-897.
48. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J.M., Stalla, G.K., Blanquet, V., Steckler, T., Holsboer, F. & Wurst, W. (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nature Genet., 19, 162-166.
49. Tjolsen, A., Berge, O.G., Hunskaar, S., Rosland, J.H. & Hole, K. (1992) The formalin test: An evaluation of the method. Pain, 51, 5-17.
50. 1 receptors in the rat central nervous system. Neuroscience, 83, 393-411.
51. Ueda, N., Kurahashi, Y., Yamamoto, S. & Tokunaga, T.J. (1995) Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem., 270, 23823-23827.
52. 1 receptors. Eur. J. Neurosci., 12 533-539.
53. Venance, L., Piomelli, D., Glowinski, J. & Giaume, C. (1995) Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature, 376, 590-594.